Digital diabetes care innovations take center stage in this summit report, examining how monitoring data and software-driven interventions can reshape clinical practice.
Key Takeaways
- Digital therapeutics were associated with an average HbA1c reduction of 0.54 percentage points
- AGP and DTx fund supported 20 investigator-initiated studies across 14 countries
- Combining CGM, AGP, and hospitalization data can identify metabolic phenotypes and treatment responses